Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Omeprazole (Prilosec) in the Atypical Patient, Administration of

Author(s):  Kane Dana Lynn

Issue:  Jan/Feb 1997 - Hospice Care
View All Articles in Issue

Page(s):  13

Omeprazole (Prilosec) in the Atypical Patient, Administration of Page 1

Download in electronic PDF format for $75

Abstract:  Omeprazole, a proton pump inhibitor indicated for peptic ulcer disease, reflux esophagitis and hypersecretory conditions, is known to be inactivated by gastric acidity. In this article, the author provides suggestions for administering omeprazole to a patient who cannot swallow the capsule whole or who has a nasogastric or gastrostomy tube or a jejunostomy tube.

Related Keywords: Enteric, Gastrotomy, Jejunostomy, Nasogastric, ph, Prilosec, Stomach, Tube

Related Categories: FORMULATIONS, GERIATRICS, PEDIATRICS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Omeprazole (Prilosec) in the Atypical Patient, Administration of
Kane Dana Lynn
Jan/Feb 1997
Pg. 13

Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes
Allen Loyd V Jr
May/Jun 2022
Pg. 214-217

Compounding Rifampin Suspensions with Improved Injectability for Nasogastric Enteral Feeding Tube Administration
de Villiers Melgardt M
, Vogel Laura, Bogenschutz Monica C, Fingerhut Bonnie J, D'Silva Joseph B, Moore Anne
May/Jun 2010
Pg. 250-256

Recommendations for Compounding Medications for Feeding Tube Administration
Klang Mark
Jul/Aug 2010
Pg. 276-282

Fluconazole 1-mg/mL Liquid for Nasogastric Tube Administration
Allen Loyd V Jr
Sep/Oct 2006
Pg. 383

Nasogastric Tube/Percutaneous Endoscopic Gastrostomy Tube Suspension Formula
Allen Loyd V Jr
Jul/Aug 2000
Pg. 304

Technology Spotlight: Tube Sealers
Jones Michael
, Adams Susan
May/Jun 2003
Pg. 206-207

Pharmaceutical Development of Enteric-Release Hard Gelatin Capsules in the Compounding Setting
de Oliveira Ferreira Anderson
, Holandino Carla
Mar/Apr 2008
Pg. 163-169

pH Stability of Injectable Fentanyl, Bupivacaine, or Clonidine Solution or a Ternary Mixture in 0.9% Sodium Chloride in Two Types of Polypropylene Syringes
Jappinen Annaliisa L
, Kokki H, Rasi A S, Naaranlahti Toivo J
Nov/Dec 2002
Pg. 471-474

Chemical Stability of Extemporaneously Compounded Omeprazole Formulations: A Comparison of Two Methods of Compounding
Garg Sanjay
, Svirskis Darren, Al-Kabban Majid, Farhan Samer, Komeshi Mohammed, Lee Jacky, Liu Quincy, Naidoo Sacha, Kairuz Therese
May/Jun 2009
Pg. 250-253

Omeprazole 2-mg/mL Oral Liquid
Allen Loyd V Jr
Sep/Oct 2006
Pg. 389

To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid
Chuong Monica C
, Taglieri Catherine A, Kerr Stephen G
Nov/Dec 2017
Pg. 500-512

Compatibility of Flavoring Agents in Compounding Extemporaneous Omeprazole Oral Liquid
Chuong Monica
, Taglieri Catherine A, Huang Szu Yu, Sariol Anthony, Kitigawa Reina, Barman Koushik, Mistry Amee, Harris Donna L, Kerr Stephen G
Nov/Dec 2019
Pg. 504-510

Patient Satisfaction with Pharmacist Intervention and Consultation in HRT
DiMaggio Jennifer Lyn
, Reed-Kane Dana
Jul/Aug 2003
Pg. 258-263

Compounding for the Pediatric Patient
Allen Loyd V Jr
Mar/Apr 1997
Pg. 84-86

pH and Osmolarity, A Review of
Stranz Marc
, Kastango Eric S
May/Jun 2002
Pg. 216-220

Compounded Medications in a Hospital Setting: Patient Counseling and Staff Education
McElhiney Linda F
May/Jun 2009
Pg. 224-229

Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents
Logomasini Mark A
, Stout Richard R, Ron Marcinkoski
Jul/Aug 2013
Pg. 270-280

Patient-centered Care as Value-added Service by Compounding Pharmacists
McPherson Timothy B
, Fontane Patrick E, Day Jonathan R
Jul/Aug 2013
Pg. 339-343

Stability of Omeprazole in SyrSpend SF Alka (Reconstituted)
Whaley Paul A
, Voudrie Mark A II, Sorenson Bridget
Mar/Apr 2012
Pg. 164-166

Return to Top